Schmoll HJ - Search Results

1

5-Fluorouracil modulation in colorectal carcinoma experience of German investigators.

Kohne-Wompner CH, Schmoll HJ. Kohne-Wompner CH, et al. Among authors: schmoll hj. Adv Exp Med Biol. 1993;339:99-107. doi: 10.1007/978-1-4615-2488-5_11. Adv Exp Med Biol. 1993. PMID: 8178734 Clinical Trial. No abstract available.

2

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Among authors: schmoll hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

3

Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.

Schmoll HJ, Köhne-Wömpner CH, Hiddemann W, Knipp H, Wilke H, Bodenstein H, Schöffski P, Bokemeyer C, Lohrmann HP, Preiss J, et al. Schmoll HJ, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):191-6. Semin Oncol. 1992. PMID: 1557646 Clinical Trial.

4

Modulation of cytotoxic drug activity by dipyridamole.

Schmoll HJ, Harstrick A, Köhne-Wömpner CH, Schöber C, Wilke H, Poliwoda H. Schmoll HJ, et al. Cancer Treat Rev. 1990 Dec;17 Suppl A:57-65. doi: 10.1016/0305-7372(90)90017-a. Cancer Treat Rev. 1990. PMID: 2092872 Review. No abstract available.

5

Chemotherapeutic strategies in metastatic colorectal cancer: an overview of current clinical trials.

Köhne-Wömpner CH, Schmoll HJ, Harstrick A, Rustum YM. Köhne-Wömpner CH, et al. Among authors: schmoll hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):105-25. Semin Oncol. 1992. PMID: 1373004 Review.

6

Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.

Bokemeyer C, Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Schöffski P, Poliwoda H. Bokemeyer C, et al. Among authors: schmoll hj. Ann Oncol. 1992 Jun;3(6):487-8. doi: 10.1093/oxfordjournals.annonc.a058243. Ann Oncol. 1992. PMID: 1498067

7

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.

Harstrick A, Bokemeyer C, Preusser P, Köhne-Wömpner CH, Meyer HJ, Stahl M, Knipp H, Schmoll HJ, Wilke H. Harstrick A, et al. Among authors: schmoll hj. Cancer Chemother Pharmacol. 1992;29(4):321-2. doi: 10.1007/BF00685952. Cancer Chemother Pharmacol. 1992. PMID: 1537080 Clinical Trial.

8

The emerging role for biomodulation of antineoplastic agents.

Schmoll HJ, Hiddemann W, Rustum Y, Köhne-Wömpner CH. Schmoll HJ, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):1-3. Semin Oncol. 1992. PMID: 1557636 No abstract available.

9

Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.

Wilke H, Stahl M, Schmoll HJ, Preusser P, Fink U, Meyer HJ, Achterrath W, Knipp H, Köhne-Wömpner CH, Harstrick A, et al. Wilke H, et al. Among authors: schmoll hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):215-9. Semin Oncol. 1992. PMID: 1557651 Review.

10

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: schmoll e, schmoll hj. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters